LATEST NEWS IN PROSTATE CANCER
A NEW CLINICAL TRIAL OPPORTUNITY | ARAMIS (BAY1841788 | ODM-201)
A new oral medication called ARAMIS is being evaluated in men who have rising PSA levels on Lupron and whose bone scans remain clear. For more information, visit: https://clinicaltrials.gov/show/NCT02200614
ARAMIS is similar to Xtandi but may have some advantages because ARAMIS is less likely to affect brain function which could reduce the likelihood of seizures and side effects...